P2B-058

State Health Centre Oncology Department (Budapest, Hungary) › P2B-058

P2B-058

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2012-12-08

withdrawn

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 nausea with onset in cycle 2 (2013-01-18); assessed as not related to study drug (not related); resolved 2013-01-20.

moderate assessed

Grade 2 alopecia with onset in cycle 1 (2013-01-15); assessed as related to study drug (probable); not resolved at last follow-up.

moderate assessed

Grade 2 stomatitis with onset in cycle 1 (2013-01-04); assessed as related to study drug (probable); resolved 2013-01-13.

moderate assessed

Grade 1 vomiting with onset in cycle 1 (2012-12-26); assessed as not related to study drug (unlikely); resolved 2012-12-28.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.